Sanofi
SNY
678 hedge funds and large institutions have $14.5B invested in Sanofi in 2023 Q1 according to their latest regulatory filings, with 103 funds opening new positions, 268 increasing their positions, 182 reducing their positions, and 56 closing their positions.
84% more first-time investments, than exits
New positions opened: 103 | Existing positions closed: 56
54% more call options, than puts
Call options by funds: $116M | Put options by funds: $75.5M
47% more repeat investments, than reductions
Existing positions increased: 268 | Existing positions reduced: 182
14% more capital invested
Capital invested by funds: $12.7B → $14.5B (+$1.74B)
5% more funds holding
Funds holding: 643 → 678 (+35)
0.71% more ownership
Funds ownership: 20.69% → 21.41% (+0.71%)
18% less funds holding in top 10
Funds holding in top 10: 17 → 14 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
+$212M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$165M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$90.3M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$75M |
| 5 |
DC
Davenport & Co
Richmond,
Virginia
|
+$55.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MSE
MUFG Securities EMEA
London,
United Kingdom
|
-$96.3M |
| 2 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$95.2M |
| 3 |
Dodge & Cox
San Francisco,
California
|
-$81.3M |
| 4 |
EP
Eversept Partners
New York
|
-$77.7M |
| 5 |
JP Morgan Chase
New York
|
-$77.4M |
SNY Hedge Fund Activity: Q1 2023 in Review
678 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q1 2023, worth a combined $14.5B — up 14% from $12.7B a quarter earlier.
Buyers outnumbered sellers: 103 funds opened new SNY positions and 56 closed out — a net gain of 47 holders — while 268 added to existing stakes and 182 trimmed.
The largest buyer was Envestnet Asset Management, adding an estimated $212M. The largest seller was MUFG Securities EMEA, exiting entirely with an estimated $96.3M sold.
- 678 institutional investors held Sanofi (SNY) as of Q1 2023, up from 643 in Q4 2022.
- Funds reported $14.5B of Sanofi stock for Q1 2023, up 14% quarter-over-quarter.
- 103 funds opened new Sanofi positions in Q1 2023 and 56 closed out, a net change of +47 holders.
- The largest Sanofi buyer in Q1 2023 was Envestnet Asset Management, an estimated $212M added.
- The largest Sanofi seller in Q1 2023 was MUFG Securities EMEA, an estimated $96.3M sold.
Based on aggregated 13F filings for Q1 2023.